NIH Guide for Grants and Contracts
November 25, 2022
Weekly NIH Funding Opportunities and Notices
General Notices
Pre-Application Webinars for NCI Cancer Screening Research Network (CSRN): ACCrual, Enrollment, and Screening Sites Hub (RFA-CA-23-020); Statistics and Data Management Center (RFA-CA-23-021); and Coordinating and Communication Center (RFA-CA-23-022)
(NOT-CA-23-017)
National Cancer Institute
Notice of Informational Webinar for PAR-23-030 "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32)"
(NOT-GM-23-026)
National Institute of General Medical Sciences
Findings of Research Misconduct
(NOT-OD-23-024)
Office of the Director, NIH
Request for Information (RFI): Priorities for Precision Cancer Prevention of Pancreatic and Liver Cancer Science at NCI
(NOT-CA-23-014)
National Cancer Institute
Request for Information: Priorities for Cancer Prevention and Symptom Management Science at NCI
(NOT-CA-23-016)
National Cancer Institute
Notice of Changes to Funding Opportunities
Notice of Correction to RFA-CA-22-050, NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)".
(NOT-CA-22-132)
National Cancer Institute
Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-026 "Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)"
(NOT-GM-23-010)
National Institute of General Medical Sciences
Clarification of Eligibility for Institutions with Multiple Campuses in PAR-22-220 "Postbaccalaureate Research Education Program (PREP) (R25 - Independent Clinical Trial Not Allowed)"
(NOT-GM-23-019)
National Institute of General Medical Sciences
Notice of Change to the Key Dates for PAR-20-049 "NINDS Postdoctoral Mentored Career Development Award (K01 - No Independent Clinical Trial Allowed)"
(NOT-NS-23-044)
National Institute of Neurological Disorders and Stroke
Notice of Change to the Key Dates for PAR-20-050 "NINDS Postdoctoral Mentored Career Development Award (K01 - Clinical Trial Required)"
(NOT-NS-23-045)
National Institute of Neurological Disorders and Stroke
Notice of Correction to Eligibility Criteria for RFA-NS-22-011 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)"
(NOT-NS-23-047)
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
(NOT-AI-23-001)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine
(NOT-AI-23-007)
National Institute of Allergy and Infectious Diseases
Notice of Special Interest (NOSI): Administrative Supplements to Prepare Data Assets for Infectious and Immune-mediated Diseases for Inclusion into the NIAID Data Ecosystem
(NOT-AI-23-009)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
Eunice Kennedy Shriver
National Institute of Child Health and Human Development
National Institute of General Medical Sciences
Notice of Special Interest (NOSI): Complement in Fundamental Immunology
(NOT-AI-23-012)
National Institute of Allergy and Infectious Diseases
Notice of Special Interest (NOSI): Advancing Research for Tickborne Diseases (TBDs)
(NOT-AI-23-013)
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Notice of Special Interest: Promoting Research Opportunities on HIV/AIDS in NIAMS
(NOT-AR-23-004)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Funding Opportunities
Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
(PAR-22-256)
National Cancer Institute
Application Receipt Date(s): November 17, 2025
Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
(PAR-23-025)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): Multiple dates, see announcement.
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
(PAR-23-026)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): Multiple dates, see announcement.
Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)
(PAR-23-030)
National Institute of General Medical Sciences
Application Receipt Date(s): January 27, 2025
Testing Centers for Development of Somatic Cell Genome Editing in Model Organisms (U42) (Clinical Trials Not Allowed)
(PAR-23-038)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): February 01, 2023
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
(PAR-23-051)
National Cancer Institute
Application Receipt Date(s): October 23, 2025
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
(PAR-23-052)
National Cancer Institute
Application Receipt Date(s): October 23, 2025
Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
(PAR-23-053)
National Institute on Aging
Office of Research on Women's Health
Application Receipt Date(s): December 02, 2025
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
(PAR-23-054)
National Institute on Aging
Office of Research on Women's Health
Application Receipt Date(s): December 02, 2025
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
(PAR-23-065)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): January 07, 2026
International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)
(RFA-AI-22-067)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): May 04, 2023
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
(RFA-FD-23-012)
Food and Drug Administration
Application Receipt Date(s): March 22, 2023
Assuring Radiation Protection (U18) Clinical Trial Not Allowed
(RFA-FD-23-018)
Food and Drug Administration
Application Receipt Date(s): February 14, 2023
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
(RFA-HD-24-006)
Eunice Kennedy Shriver
National Institute of Child Health and Human Development
National Institute of Mental Health
Application Receipt Date(s): March 29, 2023
Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional)
(RFA-MH-23-310)
National Institute of Mental Health
Application Receipt Date(s): February 17, 2023
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
(RFA-RM-23-003)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): February 03, 2023